We serve Chemical Name:4-Bromo-3,5-dimethylbenzoic acid CAS:7697-32-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Bromo-3,5-dimethylbenzoic acid
CAS.NO:7697-32-7
Synonyms:4-Brom-3,5-dimethyl-benzoesaeure;4-bromo-3,5-dimethyl-benzoic acid;20393 4-BROMO-3,5-DIMETHYLBENZOIC ACID;Benzoic acid, 4-bromo-3,5-dimethyl-;4-Bromo-3,5-dimethylbenzoic acid
Molecular Formula:C9H9BrO2
Molecular Weight:229.071
HS Code:2916399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:323.4±30.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.585
PSA:37.30000
Exact Mass:227.978592
LogP:3.78
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Brom-3,5-dimethyl-benzoesaeure chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Bromo-3,5-dimethylbenzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,20393 4-BROMO-3,5-DIMETHYLBENZOIC ACID Use and application,Benzoic acid, 4-bromo-3,5-dimethyl- technical grade,usp/ep/jp grade.
Related News: The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 4-Bromo-3,5-dimethylbenzoic acid manufacturer The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 4-Bromo-3,5-dimethylbenzoic acid supplier The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 4-Bromo-3,5-dimethylbenzoic acid vendor Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms. 4-Bromo-3,5-dimethylbenzoic acid factory International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.
